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Abstract
Background: Substantial evidence suggests that the presence of inflammatory cells plays a critical role in the development
and/or progression of human tumors. Neutrophils are the common inflammatory cells in tumors; however, the infiltration of
intratumoral neutrophils in colorectal carcinoma (CRC) and its effect on CRC patients’ prognosis are poorly understood.
Methodology/Principal Findings: In this study, the methods of tissue microarray and immunohistochemistry (IHC) were
used to investigate the prognostic significance of intratumoral CD66b+ neutrophil in CRC. According to receiver operating
characteristic curve analysis, the cutoff score for high intratumoral CD66b+ neutrophil in CRC was defined when the mean
counts were more than 60 per TMA spot. In our study, high intratumoral CD66b+ neutrophil was observed in 104/229
(45.4%) of CRCs and in 29/229 (12.7%) of adjacent mucosal tissues. Further correlation analysis showed that high
intratumoral neutrophil was positively correlated with pT status, pM status and clinical stage (P,0.05). In univariate survival
analysis, a significant association between high intratumoral neutrophil and shortened patients’ survival was found
(P,0.0001). In different subsets of CRC patients, intratumoral neutrophil was also a prognostic indicator in patients with
stage II, stage III, grade 2, grade 3, pT1, pT2, pN0 and pN1 (P,0.05). Importantly, high intratumoral neutrophil was evaluated
as an independent prognostic factor in multivariate analysis (P,0.05).
Conclusions/Significance: Our results provide evidence that increased intratumoral neutrophil in CRC may be important in
the acquisition of a malignant phenotype, indicating that the presence of intratumoral neutrophil is an independent factor
for poor prognosis of patients with CRC.
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Introduction
Colorectal carcinoma (CRC) is a leading cause of cancer-related
mortality and morbidity in the Western world, with 5-year survival
rates ranging from 90% to 10% with cancer progression [1]. In
China, CRC is the fifth leading cause of cancer related death and
the incidence continues to increase [2]. Even among patients with
CRC who undergo potentially curative resection alone, 40% to
50% of them ultimately relapse and die of metastatic disease [3].
Although tumor-nodes-metastasis (TNM) classification of CRC is
a useful tool for staging CRC patients and selecting them for
specific treatment, it is not sufficient, since many patients with the
same TNM stage may have various outcomes, suggesting that the
conventional staging procedures may be unable to precisely
predict cancer prognosis [4]. Thus, a substantial amount of
research on CRC has focused on the discovery of specific
molecular markers that are responsible for the progression of this
malignancy. To the present, however, the search and identification
of promising molecular and/or genetic alterations in CRC cells
that have clinical/prognostic significance remains substantially
limited.
The tumor microenvironment is very important with regard to
the preservation and promotion of tumor development and/or
progression. Inflammation has been identified as the seventh
hallmark of cancer [5]. An inflammatory milieu consisting of
immune/inflammatory cell and their secretory products can
promote tumor progression. The type, density and location of
tumor-infiltrating immune cells in the local microenvironment
have been related to the clinical outcome of several types of
human cancers [6,7]. Human neutrophils, initially recognized as
key effectors in the first-line host defense against invading
pathogens, are the most abundant subpopulation of leucocytes
PLoS ONE | www.plosone.org 1 January 2012 | Volume 7 | Issue 1 | e30806[8,9]. In addition to direct bactericidal activities, neutrophils can
actively regulate angiogenesis and tissue remodeling by releasing
multiple proteases [8,10]. Increased levels of neutrophils have
been found in various human tumors, and studies in mice
indicated that, depending on microenvironment, tumor-infiltrat-
ing neutrophils are capable of being pro-tumor effect [11,12,13].
Immune cells within the tumor tissues have been found to be a
better predictor of patient survival than the histopathological
methods currently used to stage CRC [6]. In addition, an elevated
neutrophil-to-lymphocyte ratio (NLR.5) of the peripheral blood,
reflecting the systemic immune response, has been correlated with
poor clinical outcome in patients with advanced CRC [14].
However, the role of tumor-infiltrating neutrophils in the local
CRC microenvironment remains to be elucidated.
Since CD66b was reported to be specifically expressed in
neutrophils [15] and it has been widely used to investigate the
neutrophil infiltration in different types of human cancer, such as
renal cell, hepatocellular and nonsmall cell cancers and melanoma
[12,16,17,18]. In the present study, therefore, the IHC staining of
CD66b was utilized to investigate the clinical/prognostic signif-
icance of intratumoral neutrophils in a cohort of CRCs. Herein,
we report, for the first time, that increased intratumoral
neutrophils, as detected by IHC, correlate closely with CRC
malignant phenotype and is an independent predictor for
shortened survival time of patients with CRC.
Materials and Methods
Ethics statement
The study was approved by the Institute Research Medical
Ethics Committee of Sun Yat-Sen University. No informed
consent (written or verbal) was obtained for use of retrospective
tissue samples from the patients within this study, most of whom
were deceased, since this was not deemed necessary by the Ethics
Committee, who waived the need for consent. All samples were
anonymised.
Patients and tissue specimens
In this study, the paraffin-embedded pathologic specimens from
229 patients with CRC were obtained from the archives of
Department of Pathology, Sun Yat-Sen University Cancer Center
and Guangdong Provincial People’s Hospital, Guangzhou, China,
between January 2000 and November 2006. All these resection
samples have a uniform fixation, dissection and processing
protocol. The cases selected were based on distinctive pathologic
diagnosis of CRC, undergoing primary and curative resection for
CRC, availability of resection tissue, follow-up data, and had not
received preoperative anticancer treatment. These CRC cases
included 142 (62.0%) men and 87 (38.0%) women, with mean age
of 57.3 years. Average follow-up time was 55.42 months (median,
60.0 months; range, 0.5 to 98 months). These patients, whose
diseases encompassed 171 (74.7%) colon cancers (including 89 left-
sided colon and 82 right-sided colon cancers) and 58 (25.3%)
rectal cancers, underwent initial surgical treatment in our institute.
The mean lymph node yield for each resected colorectal cancer
was 15. The diagnostic examinations including MRI, CT, chest X-
ray, abdominal ultrasonography and bone scan were utilized to
identify CRC distal metastasis. The pTNM status of all CRCs was
assessed according to the criteria of the sixth edition of the TNM
classification of the International Union Against Cancer (UICC,
2002). Clinicopathologic characteristics for these patients were
detailed in table 1. Patients whose cause of death remained
unknown or received preoperative radiation or chemotherapy
were excluded from our study. In addition, for analyzing the levels
of neutrophil infiltration in CRC lymph node metastasis, 30 cases
of lymph node metastatic samples from our CRC cohort were
selected and studied.
Tissue microarray (TMA) and immunohistochemistry
(IHC)
TMAs were constructed in accordance with a previously-
described method [19]. Triplicate 0.6 mm diameter cylinders
from the center of the tumor away from areas of ulceration/
necrosis were punched from representative areas of an individual
donor tissue block, and re-embedded into a recipient paraffin
block in a defined position, using a tissue arraying instrument
(Beecher Instruments, Silver Spring, MD).
The TMA blocks were cut into 5-mm sections and processed for
IHC in accordance with a previously-described protocol [20].
TMA slides were incubated with anti-CD66b ((BD Transduction
Laboratories, Franklin Lakes, NJ, 1:1000 dilution) and anti-CD3
Table 1. Correlation between the clinicopathologic variables
and intratumoral CD66b+ neutrophil in colorectal carcinoma.
Intratumoral CD66b+ neutrophil
All cases Low High P value
*
Sex 0.492
Female 87 50 (57.5%) 37 (42.5%)
Male 142 75 (52.8%) 67 (47.2%)
Age at diagnosis (years) 0.990
#57.3
{ 108 59 (54.6%) 49 (45.4%)
.57.3 121 66 (54.5%) 55 (45.5%)
Tumor location 0.084
Colon 171 99 (57.9%) 72 (42.1%)
Rectum 58 26 (44.8%) 32 (55.2%)
Histological grade (WHO) 0.264
G1 19 13 (68.4%) 6 (31.6%)
G2 174 90 (51.7%) 84 (48.3%)
G3 36 22 (61.1%) 14 (38.9%)
pT status 0.039
1 16 13 (81.3%) 3 (18.7%)
2 76 44 (57.9%) 32 (42.1%)
3 129 66 (51.2%) 63 (48.8%)
4 8 2 (25.0%) 8 (75.0%)
pN status 0.258
0 169 96 (56.8%) 73 (43.2%)
1 60 29 (48.3%) 31 (51.7%)
pM status 0.001
pMX 206 120 (58.3%) 86 (41.7%)
pM1 23 5 (21.7%) 18 (78.3%)
Clinical stage 0.002
I 74 49 (66.2%) 25 (33.8%)
II 76 44 (57.9%) 32 (42.1%)
III 56 27 (48.2%) 29 (51.8%)
IV 23 5 (21.7%) 18 (78.3%)
*Chi-square test;
{Mean age;
WHO indicated World Health Organization.
doi:10.1371/journal.pone.0030806.t001
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tively, and stored overnight at 4uC. Immunostaining was
performed using the Envision System with diaminobenzidine
(Dako, Glostrup, Denmark). A negative control was obtained by
replacing the primary antibody with a normal murine or rabbit
IgG. In the case of non-informative TMA samples (i.e., samples
with ,500 tumor cells per case and lost samples), IHC staining
was performed by using whole tissue slides.
IHC evaluation
Microarray was evaluated at 2006magnification light micros-
copy by two independent pathologists (H-L. Rao and M-Y. Cai)
who were blinded to the clinicopathological data of these CRC
patients. For CD66b and CD3 IHC staining, positive cells in each
0.6-mm-diameter cylinder were counted and expressed as mean
value of the triplicates.
Selection of cutoff score
Receiver operating characteristic (ROC) curve analysis was
performed to determine cutoff score for tumor with increased
intratumoral neutrophil by using the 0,1-criterion [21]. At the
intratumoral neutrophil counts, the sensitivity and specificity for each
outcome under study was plotted, thus generating various ROC
curves (Figure 1). The count was selected as the cutoff value, which
was closest to the point with both maximum sensitivity and specificity.
Tumors designated as decreased intratumoral neutrophils were those
with the scores below or equal to the cutoff value, while tumors of
increased intratumoral neutrophils were those with scores above the
value. In order to use ROC curve analysis, the clinicopathological
features were dichotomized: histological grade (G1–G2 or G3), pT
status (T1–T2 or T3–T4), pN status (N0 or N1), pM status (pMX or
pM1), clinical stage (I+II or III+IV) and survival (death due to CRC or
censored [lost to follow-up, alive or death from other causes]).
Statistical analysis
Statistical analysis was performed by using the SPSS statistical
software package (standard version 13.0; SPSS, Chicago, IL).
ROC curve analysis was applied to determine the cutoff score for
increased intratumoral neutrophils and T lymphocytes. The
correlation between increased intratumoral neutrophils and
clinicopathological features of CRC patients was analyzed by x
2-
test. For univariate survival analysis, survival curves were obtained
with the Kaplan-Meier method. The Cox proportional hazards
regression model was used to identify the independent prognostic
factors. Differences were considered significant if the P-value from
a two-tailed test was less than 0.05.
Results
The pattern of CD66b+ neutrophil in colorectal tissues
To investigate the pattern of neutrophil in carcinomatous and
non-neoplastic human colorectal tissues, we conducted IHC
Figure 1. ROC curve analysis was employed to determine the cutoff value for high intratumoral CD66b+ neutrophil in colorectal
carcinoma. The sensitivity and specificity for each outcome were plotted: tumor grade (P=0.575, A), T stage (P=0.029, B), N stage (P=0.263, C), M
stage (P=0.002, D), clinical stage (P=0.005, E), and survival status (P,0.001, F).
doi:10.1371/journal.pone.0030806.g001
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primary CRC specimens and corresponding normal colorectal
mucosa, and on 30 samples (whole tissue slides) of CRC lymph
node metastasis. We examined that CD66b+ neutrophils were
localized primarily in the stroma of CRC and colorectal mucosal
tissues. IHC staining of CD66b in representative samples of CRC,
adjacent normal colorectal mucosa and lymph node metastatic
tissues were shown in Figure 2. The counts of intratumoral
CD66b+ neutrophil in CRC tissues ranged from 0 to 135.0 per
TMA spot, with median count of 45.0.
Selection of cutoff score for high intratumoral CD66b+
neutrophil in CRC
The ROC curves for each clinicopathologic feature (Figure 1)
show the value on the curve closest to the point (i.e., 0.0, 1.0),
which maximizes both sensitivity and specificity for the outcome
[21]. Tumors with counts above the obtained cutoff value were
considered as high intratumoral neutrophil leading to the greatest
number of tumors correctly classified as having or not having the
clinical outcome. The corresponding area under the curve (AUC)
were collected and shown in Table 2. In our current study, ROC
curve analysis for pM status had the shortest distance from the
curve to the point (i.e., 0.0, 1.0), and we selected the cutoff value
determined by pM status. Thus, the cutoff score for high
intratumoral CD66b neutrophil in CRC was defined when the
mean counts were more than 60 per TMA spot.
The association of the increased intratumoral neutrophil
with CRC patients’ clinicopathologic features
According to ROC curve, high intratumoral CD66b+ neutro-
phil was examined in 29/229 (12.7%) of normal colorectal
mucosal tissues, in 104/229 (45.4%) of primary CRC tissues and
in 16/30 (53.3%) of lymph node metastatic CRC tissues (P,0.001,
Chi-square test). There is no significant difference of CD66b+
neutrophil infiltration in primary CRC and lymph node metastatic
CRC tissues (P=0.413). The rates of high intratumoral neutrophil
in CR with respect to several standard clinicopathologic features
were detailed in Table 1. The results showed that increased
intratumoral neutrophil was positively correlated with tumor pT
status, pM status and advanced clinical stage (P,0.05, Table 1).
There was no significant association between intratumoral
CD66b+ neutrophil and other clinicopathologic features, such as
patient gender, age, histological grade and pN status (P.0.05,
Table 1).
Association between clinicopathologic characteristics,
intratumoral CD66b+ neutrophil, and CRC patient
survival: univariate survival analysis
To confirm the representativeness of the CRC cohort in our
study, we first tested well-established prognostic factors of patient
survival. Kaplan–Meier analysis evaluated a significant impact of
well-known clinicopathologic prognostic parameters, such as pT
status (P=0.012), pN status (P,0.0001), pM status (P,0.0001),
and clinical stage (P,0.0001) on patients’ survival (Table 3).
Assessment of survival in our CRC cohort demonstrated that the
increased intratumoral CD66b+ neutrophil was correlated with
adverse disease-specific survival (P,0.0001, Figure 3A and
Table 3). Moreover, survival analysis was performed with regard
to intratumoral CD66b+ neutrophil infiltration in subsets of CRC
patients with different clinical stage (Figure 3B–3D), histological
grade (Figure 4A and 4B) and pT/pN status (Figure 4C–4F). Our
results demonstrated as well that high intratumoral neutrophil was
a prognostic factor in CRC patients with stage II (P,0.001,
Figure 3B), stage III (P=0.005, Figure 3C), grade 2 (P,0.001,
Figure 4A), grade 3 (P=0.014, Figure 4B), pT1 (P,0.001,
Figure 4C), pT2 (P,0.001, Figure 4D), pN0 (P,0.001,
Figure 2. The presence of CD66b+ neutrophils in colorectal and lymph node metastatic CRC tissues. (A) High intratumoral neutrophil
was observed in a CRC (case 52), in which more than 60 intratumoral cells revealed positive immunostaining of CD66b (upper panel,6100). (B) A CRC
case (case 37) demonstrated low intratumoral neutrophil, in which less than 60 intratumoral cells showed immunoreactivity of CD66b (upper panel,
6100). (C) The corresponding adjacent mucosal tissue of case 52 showed low neutrophil, in which less than 60 cells revealed immunostaining of
CD66b (upper panel,6100). (D) High intratumoral neutrophil was observed in lymph node metastatic tissue, in which more than 60 intratumoral cells
revealed positive immunostaining of CD66b (upper panel,6100). The lower panels indicated the higher magnification (6400) from the area of the box
in A, B and C, respectively.
doi:10.1371/journal.pone.0030806.g002
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differentiate the outcome of stage I (not reached), stage IV patients
(P.0.05, Figure 3D), grade 1 (not reached), pT1 (not reached), or
pT4 (P.0.05, data not shown).
Independent prognostic factors of CRCs: multivariate
survival analysis
Since variables observed to have prognostic influence by
univariate analysis may covariate, the count of intratumoral
neutrophil as well as other clinicopathologic features (pT status,
pN status, pM status and clinical stage) that were significant in
univariate analysis were analyzed in multivariate analysis (Table 3).
We found that the increased intratumoral CD66b+ neutrophil was
evaluated as an independent risk factor for adverse overall patient
survival (hazards ratio: 2.040; 95% confidence interval: 1.186–
3.843;P=0.010).Of the othervariables, pTstatuswasalsofoundto
beanindependentprognosticpredictorforoverallsurvival(Table3).
Correlation between the neutrophil and T cell infiltration
in CRCs
Similarly,byutilizingtheROCcurveanalysis,thecutoffscorefor
high intratumoral CD3+ T lymphocyte in CRC was defined when
the mean counts were more than 76 per TMA spot. High
intratumoral CD3+ T cell was detected in 112/229 (48.9%) of
Table 2. Area under the receiver (AUC) operating
characteristic curve for each clinicopathological feature.
Feature AUC (95% CI) P value
Grade 0.471 (0.377 to 0.564) 0.575
T stage 0.585 (0.510 to 0.661 ) 0.029
N stage 0.549 (0.462 to 0.635) 0.263
M stage 0.699 (0.594 to 0.805) 0.002
Stage 0.612 (0.535 to 0.689) 0.005
Survival 0.662 (0.584 to 0.740) ,0.001
CI indicates confidence interval.
doi:10.1371/journal.pone.0030806.t002
Table 3. Univariate and multivariate analysis of different prognostic factors in 229 patients with colorectal carcinoma.
Variable Univariate analysis
* Multivariate analysis
{
All cases
Mean survival
(months)
Chi-square
value P value HR (95% CI) P value
Sex 0.176 0.675
Female 87 76.7
Male 142 74.6
Age at surgery (years) 0.005 0.943
#57.3
{ 108 74.5
.45 121 75.5
Tumor location 0.161 0.688
Colon 171 76.1
Rectum 58 72.4
Histological grade (WHO) 2.291 0.130
G1–2 193 77.4
G3 36 64.8
pT status 12.466 0.000 0.026
T1–T2 92 84.9 1.0
T3–T4 137 68.7 1.951 (1.084–3.511)
pN status 14.216 0.000 0.387
N0 169 80.3 1.0
N1–N2 60 63.4 1.578 (0.562–4.427)
pM status 75.992 0.000 0.283
pMX 206 80.5 1.0
pM1 51 28.2 2.594 (0.455–14.784)
Clinical stage 48.891 0.000 0.336
I–II 150 86.5 1.0
III–IV 79 55.4 1.558 (0.632–3.843)
Intratumoral CD66b+ neutrophil 48.675 0.000 0.010
Low 125 88.8 1.0
High 104 60.0 2.040 (1.186–3.507)
*Log-rank test;
{Cox regression model;
{Mean age;
HR indicates hazards ratio; CI indicates confidence interval; WHO indicates World Health Organization.
doi:10.1371/journal.pone.0030806.t003
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statistically significant correlation between expression of neutrophil
and T lymphocyte infiltration in our CRC cohort (P=0.144,
Fishers exact test).
Discussion
It has been long recognized that many human cancer types are
accompanied by inflammatory cell infiltration of varying intensity.
Most attention has been paid to a possible role of inflammatory
cells, due to their obvious immunological correlation. Recent
studies have elucidated the role of distinct immune cells, cytokines,
and other immune mediators in virtually all steps of colorectal
tumorigenesis, including initiation, promotion, progression and
metastasis. In addition, the type, density and location of T
lymphocytes, CD8 T cell effectors and their associated cytotoxic
molecule, and memory T cells in CRCs had a prognostic value
that was superior to and independent of the TNM classification
Figure 3. Survival curves for 229 CRC patients according to infiltration status of intratumoral neutrophils (log-rank test). (A) Total,
probability of survival of all patients with CRC: low intratumoral neutrophil, n=125; high intratumoral neutrophil, n=104. (B) Stage II, probability of
survival of stage II patients with CRC: low intratumoral neutrophil, n=44; high intratumoral neutrophil, n=32. (C) Stage III, probability of survival of
stage III patients with CRC: low intratumoral neutrophil, n=27; high intratumoral neutrophil, n=29. (D) Stage IV, probability of survival of stage IV
patients with CRC: low intratumoral neutrophil, n=5; high intratumoral neutrophil, n=18.
doi:10.1371/journal.pone.0030806.g003
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PLoS ONE | www.plosone.org 6 January 2012 | Volume 7 | Issue 1 | e30806Figure 4. Survival curves according to infiltration status of intratumoral neutrophils in subsets of CRC patients with different
histological grade and pT/pN status (log-rank test). (A) Grade 2, probability of survival of grade 2 patients with CRC: low intratumoral
neutrophil, n=93; high intratumoral neutrophil, n=81. (B) Grade 3, probability of survival of grade 3 patients with CRC: low intratumoral neutrophil,
n=20; high intratumoral neutrophil, n=16. (C) pT2, probability of survival of pT2 patients with CRC: low intratumoral neutrophil, n=45; high
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neutrophils in CRCs has not been well understood.
In the presents study, we utilized the methods of TMA and IHC
to investigate the clinicopathologic significance of the intratumoral
CD66b+ neutrophils in CRC tissues. Our current study
established that neutrophils could be detected in most of
intratumoral stroma of CRC and lymph node metastatic tissues
by IHC, and that increased intratumoral neutrophil was positively
correlated with CRC pT status, pM status and advanced clinical
stage. Moreover, univariate and multivariate analyses evaluated
that increased intratumoral neutrophil was a prognostic factor
independent of certain well-established clinical features, including
tumor pT status, pN status, pM status and clinical stage. Thus,in
this study, our results provided evidence that increased intratu-
moral neutrophil in CRC may facilitate an increased malignant
and/or worse prognostic phenotype of the tumor.
As a canonical leucocyte subpopulation, human neutrophils
have been recognized as a first-line defender against infectious
microorganisms. However, neutrophils are a source of N-
nitrosamines, especially in the presence of colonic amine
producing bacteria, and these are known to be carcinogenesis
[22,23]. Campreqher et al [24] reported that activated neutrophils
induced an hMSH2-dependent G2/M checkpoint arrest and
replication errors in colon epithelial cells. Previous study showed
that infiltration of neutrophils was increased in colorectal
adenomas compared to adjacent normal mucosa and correlated
with adenoma size, suggesting that the presence of neutrophils is
involved in the early stage of colorectal tumorigenesis [25].
Recently, expression of neutrophil gelatinase-associated lipocalin
(NGAL) has been shown to be elevated in both colorectal
adenoma-carcinoma sequence and cancer progression and
enhances tumorigenesis in mouse models [26]. Also, overexpres-
sion of NGAL in CRCs is an important regulatory molecule that
integrates extracellular environment cues, iron metabolism, and
intracellular small GTPase signaling in cancer migration and
invasion [27]. These findings are in line with our observations,
suggesting intratumoral neutrophils as an adverse prognostic
factor for CRC.
In our study, moreover, increased intratumoral CD66b+
neutrophil was also frequently found in CRC lymph node
metastatic tissues and it was positively correlated to the metastatic
phenotype of CRC. Neutrophil elastase, is a main constituent of
phagocytic response, degrading proteins within the local environ-
ment such as elastin, collagen and other constituents of
extracellular matrix [28]. It was demonstrated that neutrophil
and macrophage derived MMP-9 enhanced progression from
dysplasia to overt malignancy in a mouse model of skin squamous
carcinoma, with reduced MMP-9 delaying angiogenesis within
dysplastic areas and reducing the incidence of invasive disease
[29]. Moreover, it has been suggested that the accumulated
neutrophils in the peritumoral stroma of HCC are the major
source of MMP-9, which in turn trigger the angiogenic switch at
the adjacent invading edge [30]. These data, taken together, might
provide a possible explanation that in our present study, why the
increased intratumoral neutrophil was positively correlated with
distant metastasis in CRCs.
The impact of neutrophil infiltrates on the prognosis in CRC
patients remained controversial. Nielsen et al found that the high
peritumoral neutrophil cell counts had a good prognostic impact
on CRC patients by assessing H&E staining slides [31]. In our
study, the increased intratumoral CD66b+ neutrophil was
associated closely with CRC patients’ shorter survival time and
evaluated as an independent risk factor for poor overall survival.
Other groups reported that the presence of intratumoral
neutrophils was an adverse prognostic factor for HCC after
resection [16]. In addition, accumulation of neutrophils in
peritumoral stroma was found to foster disease progression and
predict reduced survival in HCC patients [30]. Furthermore,
Jensen and colleagues [12] observed that neutrophil infiltration in
renal cell carcinoma (RCC) specimens was correlated with poor
prognosis in localized RCC. Taken together, CRC cells often
recruit a wide variety of inflammatory cells to their microenvi-
ronment, resulting in tumor progression; while in peritumoral
stroma, the peritumoral neutrophils might provide a protective
role to inhibit CRC growth.
Thus, the examination of intratumoral neutrophil in CRCs,
could be used as an additional effective tool in identifying those
CRC patients at increased risk of tumor metastasis and/or
progression. This might also aid the clinician to select a suitable
therapy for the individual patient, e.g. favoring a more aggressive
regimen in tumors with an increased intratumoral neutrophil.
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